Literature DB >> 22067959

Vascular risk factors and cognitive impairment in a stroke-free cohort.

F W Unverzagt1, L A McClure, V G Wadley, N S Jenny, R C Go, M Cushman, B M Kissela, B J Kelley, R Kennedy, C S Moy, V Howard, G Howard.   

Abstract

OBJECTIVE: To examine vascular risk factors, as measured by the Framingham Stroke Risk Profile (FSRP), to predict incident cognitive impairment in a large, national sample of black and white adults age 45 years and older.
METHODS: Participants included subjects without stroke at baseline from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study with at least 2 cognitive function assessments during the follow-up (n = 23,752). Incident cognitive impairment was defined as decline from a baseline score of 5 or 6 (of possible 6 points) to the most recent follow-up score of 4 or less on the Six-item Screener (SIS). Subjects with suspected stroke during follow-up were censored.
RESULTS: During a mean follow-up of 4.1 years, 1,907 participants met criteria for incident cognitive impairment. Baseline FSRP score was associated with incident cognitive impairment. An adjusted model revealed that male sex (odds ratio [OR] = 1.59, 95% confidence interval [CI] 1.43-1.77), black race (OR = 2.09, 95% CI 1.88-2.35), less education (less than high school graduate vs college graduate, OR = 2.21, 95% CI 1.88-2.60), older age (10-year increments, OR = 2.11, per 10-year increase in age, 95% CI 2.05-2.18), and presence of left ventricular hypertrophy (LVH, OR = 1.29, 95% CI 1.06-1.58) were related to development of cognitive impairment. When LVH was excluded from the model, elevated systolic blood pressure was related to incident cognitive impairment.
CONCLUSIONS: Total FSRP score, elevated blood pressure, and LVH predict development of clinically significant cognitive dysfunction. Prevention and treatment of high blood pressure may be effective in preserving cognitive health.

Entities:  

Mesh:

Year:  2011        PMID: 22067959      PMCID: PMC3208949          DOI: 10.1212/WNL.0b013e318236ef23

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

2.  Stroke risk predicts verbal fluency decline in healthy older men: evidence from the normative aging study.

Authors:  C B Brady; A Spiro; R McGlinchey-Berroth; W Milberg; J M Gaziano
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2001-11       Impact factor: 4.077

3.  Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study.

Authors:  E M C Schrijvers; J C M Witteman; E J G Sijbrands; A Hofman; P J Koudstaal; M M B Breteler
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

4.  Cardiovascular risk factors and cognitive decline in middle-aged adults.

Authors:  D Knopman; L L Boland; T Mosley; G Howard; D Liao; M Szklo; P McGovern; A R Folsom
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

5.  Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.

Authors:  M Kivipelto; E L Helkala; T Hänninen; M P Laakso; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

6.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

7.  Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.

Authors:  Susanna Tervo; Miia Kivipelto; Tuomo Hänninen; Matti Vanhanen; Merja Hallikainen; Arto Mannermaa; Hilkka Soininen
Journal:  Dement Geriatr Cogn Disord       Date:  2004-01-20       Impact factor: 2.959

8.  Framingham stroke risk profile and lowered cognitive performance.

Authors:  Merrill F Elias; Lisa M Sullivan; Ralph B D'Agostino; Penelope K Elias; Alexa Beiser; Rhoda Au; Sudha Seshadri; Charles DeCarli; Philip A Wolf
Journal:  Stroke       Date:  2004-01-15       Impact factor: 7.914

9.  Risk factors for dementia in the cardiovascular health cognition study.

Authors:  Lewis H Kuller; Oscar L Lopez; Anne Newman; Norman J Beauchamp; Greg Burke; Corinne Dulberg; Annette Fitzpatrick; Linda Fried; Mary N Haan
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

10.  Six-item screener to identify cognitive impairment among potential subjects for clinical research.

Authors:  Christopher M Callahan; Frederick W Unverzagt; Siu L Hui; Anthony J Perkins; Hugh C Hendrie
Journal:  Med Care       Date:  2002-09       Impact factor: 2.983

View more
  71 in total

Review 1.  Brain health and shared risk factors for dementia and stroke.

Authors:  Hannah Gardener; Clinton B Wright; Tatjana Rundek; Ralph L Sacco
Journal:  Nat Rev Neurol       Date:  2015-10-20       Impact factor: 42.937

2.  Midlife cardiovascular risk impacts executive function: Framingham offspring study.

Authors:  Arvind Nishtala; Sarah R Preis; Alexa Beiser; Sherral Devine; Lisa Hankee; Sudha Seshadri; Philip A Wolf; Rhoda Au
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

3.  Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.

Authors:  S R Gillett; L A McClure; P W Callas; E L Thacker; F W Unverzagt; V G Wadley; A J Letter; M Cushman
Journal:  J Thromb Haemost       Date:  2018-06-06       Impact factor: 5.824

Review 4.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

5.  Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.

Authors:  Hiroko H Dodge; Jian Zhu; Randy Woltjer; Peter T Nelson; David A Bennett; Nigel J Cairns; David W Fardo; Jeffrey A Kaye; Deniz-Erten Lyons; Nora Mattek; Julie A Schneider; Lisa C Silbert; Chengjie Xiong; Lei Yu; Frederick A Schmitt; Richard J Kryscio; Erin L Abner
Journal:  Alzheimers Dement       Date:  2016-12-23       Impact factor: 21.566

6.  Cognitive activity mediates the association between social activity and cognitive performance: A longitudinal study.

Authors:  Cassandra L Brown; Annie Robitaille; Elizabeth M Zelinski; Roger A Dixon; Scott M Hofer; Andrea M Piccinin
Journal:  Psychol Aging       Date:  2016-12

7.  Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments.

Authors:  Virginia G Wadley; Leslie A McClure; David G Warnock; Caroline L Lassen-Greene; Robert J Hopkin; Dawn A Laney; Virginia M Clarke; Manjula Kurella Tamura; George Howard; Katherine Sims
Journal:  JIMD Rep       Date:  2015-01-08

8.  Health risk prediction models incorporating personality data: Motivation, challenges, and illustration.

Authors:  Benjamin P Chapman; Feng Lin; Shumita Roy; Ralph H B Benedict; Jeffrey M Lyness
Journal:  Personal Disord       Date:  2019-01

9.  Individual differences in regional cortical volumes across the life span are associated with regional optical measures of arterial elasticity.

Authors:  Antonio M Chiarelli; Mark A Fletcher; Chin Hong Tan; Kathy A Low; Edward L Maclin; Benjamin Zimmerman; Tania Kong; Alexander Gorsuch; Gabriele Gratton; Monica Fabiani
Journal:  Neuroimage       Date:  2017-09-01       Impact factor: 6.556

10.  Vascular risk and FDDNP-PET influence cognitive performance.

Authors:  David A Merrill; Prabha Siddarth; Vladimir Kepe; Pushpa V Raja; Nathan Saito; Linda M Ercoli; Karen J Miller; Helen Lavretsky; Susan Y Bookheimer; Jorge R Barrio; Gary W Small
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.